THE Northern Ireland-based pharmaceutical giant Almac has announced further investment plans for its £30m (€34m) site in Co Louth, a move protecting it against Brexit uncertainty. THE Northern Ireland-based pharmaceutical giant Almac has announced further investment plans for its £30m (€34m) site in Co Louth, a move protecting it against Brexit uncertainty. Chief executive and chairman Alan Armstrong said: "Achieving these successful Health Products Regulatory Authority (HPRA) inspections is a key milestone." The company said it had invested in all its operations and workforces over the last 18 months across the US, Asia and UK. As well as operations in Ireland and Britain, Almac has bases in the US, Singapore and Japan.

Source: Irish Independent January 19, 2018 02:26 UTC